1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI : The ProScreen Randomized Trial
- Contribution to journal › Article
- 2022
-
Mark
Population-based randomized trial of screening for clinically significant prostate cancer ProScreen : a pilot study
- Contribution to journal › Article
- 2019
-
Mark
A Four-kallikrein Panel and β-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy : An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer
- Contribution to journal › Article
-
Mark
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
- Contribution to journal › Article
- 2014
-
Mark
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
- Contribution to journal › Article
- 2012
-
Mark
Prostate-Cancer Mortality at 11 Years of Follow-up
- Contribution to journal › Article
